Dedicated Endoscopy for Barrett's Oesophagus (DEBO) compared to current Barrett’s oesophagus surveillance endoscopy practice

Not Applicable

Completed

• Conditions: Barrett's oesophagus; Digestive System

• Registration Number: ISRCTN12259569
• Lead Sponsor: Salford Royal NHS Foundation Trust

Brief Summary

2023 Preprint results in https://doi.org/10.1016/j.igie.2023.11.003 (added 26/02/2024)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-08-12
• Study Completion: 2023-01-01
• Last Update Posted: 11 March 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1. Has the capacity to give informed consent
2. Aged >18 years old
3. Diagnosis of non-dysplastic Barrett's oesophagus

Exclusion Criteria

1. Previous diagnosis of precancerous changes
2. Unable to understand written English to a standard at which they can understand the questionnaire

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility of a randomised controlled trial comparing a dedicated endoscopy service for Barrett's oesophagus versus current normal practice, measured using health-related quality of life questionnaire completed at 6 weeks post endoscopic surveillance and histological outcomes of endoscopy (no dysplasia, intestinal metaplasia, low-grade dysplasia, or high-grade dysplasia) measured at either the time of dedicated surveillance endoscopy session (intervention arm) or at normally scheduled endoscopy session (control arm)

Secondary Outcome Measures

Name	Time	Method
There are no secondary outcome measures